Compare TECH & VNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TECH | VNO |
|---|---|---|
| Founded | 1976 | 1946 |
| Country | United States | United States |
| Employees | 3100 | 3145 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 6.3B |
| IPO Year | 1995 | N/A |
| Metric | TECH | VNO |
|---|---|---|
| Price | $57.75 | $37.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 10 |
| Target Price | ★ $71.82 | $33.00 |
| AVG Volume (30 Days) | ★ 2.5M | 1.6M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | 0.62% | ★ 2.52% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.81 | N/A |
| Revenue | ★ $1,219,635,000.00 | N/A |
| Revenue This Year | $2.49 | N/A |
| Revenue Next Year | $6.40 | $5.42 |
| P/E Ratio | $71.12 | ★ $7.08 |
| Revenue Growth | ★ 5.23 | N/A |
| 52 Week Low | $43.20 | $24.57 |
| 52 Week High | $72.16 | $43.37 |
| Indicator | TECH | VNO |
|---|---|---|
| Relative Strength Index (RSI) | 65.24 | 65.56 |
| Support Level | $57.46 | $33.23 |
| Resistance Level | $57.99 | $39.62 |
| Average True Range (ATR) | 1.92 | 1.15 |
| MACD | 0.72 | 0.01 |
| Stochastic Oscillator | 96.63 | 76.45 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Vornado Realty Trust is a fully integrated real estate investment trust with a portfolio of New York City office, retail, and multifamily assets, and the developer of the new Penn District. While concentrated in New York, the trust also owns assets in both Chicago and San Francisco. It generates revenue in the form of property rentals, fees charged for trade shows, parking revenues, management and leasing fees, etc. Vornado operates in the following reportable segments: New York (its key revenue-generating market) and Other.